| Literature DB >> 34276157 |
Jagadeesh Menon1, Mukul Vij2, Abdul R Hakeem3, Kakumudi Rajagopal Gopi4, Asma Bibi5, Naresh Shanmugam1, Mettu S Reddy3, Mohamed Rela3,6.
Abstract
INTRODUCTION: Posttransplant lymphoproliferative disorder (PTLD) is a rare complication seen in the period after liver transplant. The commonest subtype is B-cell PTLD which is usually associated with Epstein-Barr virus (EBV) infection. T-cell PTLD is rare and the association with EBV is again rarer. CASE: Our patient, a 21-year-old young adult, presented to us with generalized lymphadenopathy, 5 years after liver transplantation. The biopsy of the lymph node was suggestive of peripheral T-cell lymphoma not otherwise specified, which was associated with EBV infection. The Positron emission tomography and computerised tomography (PET-CT) scan showed stage 3 disease. He was treated with standard cyclophosphamide, doxorubicin, etoposide, vincristine, and prednisolone chemotherapy and is currently in remission.Entities:
Keywords: CHOEP, Cyclophosphamide, Doxorubicin, Etoposide, Vincristine, Prednisolone; EBV, Epstein-Barr Virus; Epstein-Barr virus; NK, Natural Killer Cells; PET, Positron Emission Tomography; PTLD NOS, Posttransplant Lymphoproliferative Disorder Not Otherwise Specified; PTLD, Posttransplant Lymphoproliferative Disorder; chemotherapy; liver transplantation; peripheral T-cell lymphoma not otherwise specified; remission
Year: 2020 PMID: 34276157 PMCID: PMC8267348 DOI: 10.1016/j.jceh.2020.09.002
Source DB: PubMed Journal: J Clin Exp Hepatol ISSN: 0973-6883